> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Comments Sought on Patent Listing in Orange Book
- URL: https://www.fdaweb.com/comments-sought-on-patent-listing-in-orange-book/
- Published: 2020-06-01T12:00:00.000Z
- Updated: 2026-09-14T16:16:37.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5146898

*Federal Register* notice: FDA has established a docket to solicit comments on the listing of patent information in the agency’s “Approved Drug Products With Therapeutic Equivalence Evaluations”( the *Orange Book*). FDA is seeking comments on the types of patents currently listed in the *Orange Book* and the impact that any change to current patent listing practices may have on drug product development. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2020-06-01/pdf/2020-11684.pdf?ref=fdaweb.com).